| Q28072523 | Community acquired respiratory virus infections in cancer patients-Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical Oncology |
| Q37426542 | Diagnosis and treatment of viral diseases in recipients of allogeneic hematopoietic stem cell transplantation |
| Q47848155 | Frequent detection of respiratory viruses in adult recipients of stem cell transplants with the use of real-time polymerase chain reaction, compared with viral culture |
| Q30383456 | How I treat influenza in patients with hematologic malignancies. |
| Q36913826 | Impact of corticosteroid treatment and antiviral therapy on clinical outcomes in hematopoietic cell transplant patients infected with influenza virus |
| Q45115470 | Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy |
| Q27011595 | Influenza prevention and treatment in transplant recipients and immunocompromised hosts |
| Q34759825 | Oseltamivir-resistant influenza A and B viruses pre- and postantiviral therapy in children and young adults with cancer |
| Q35945742 | Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies |
| Q26829188 | Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients |
| Q37751364 | Respiratory viral infections in transplant and oncology patients |
| Q35184878 | Respiratory virus infections in the immunocompromised host |
| Q40413531 | Serum IgM levels independently predict immune response to influenza vaccine in long-term survivors vaccinated at >1 year after undergoing allogeneic hematopoietic stem cell transplantation |
| Q37266577 | The challenge of respiratory virus infections in hematopoietic cell transplant recipients |
| Q47581987 | The clinical features and outcome of 2009 H1N1 influenza infection in allo-SCT patients: a British Society of Blood and Marrow Transplantation study. |
| Q22305944 | Vaccination of the immunocompromised child |
| Q37788451 | Viral pneumonias in immunocompromised adult hosts |
| Q35124722 | Zanamivir in the treatment of influenza |